MedTrace Logo

Prospective Registry to Evaluate the Effective Incidence of Chronic Thromboembolic Pulmonary Hypertension in Germany

NCT02660463 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2016-01-21

No results posted yet for this study

Summary

The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) after acute pulmonary embolism ist not clear. It is estimated to be up to 3.8%. Prospective data registration does not exist. Treatment of choice is pulmonary endarterectomy if the thromboembolic lesions are surgically accessible. Otherwise interventional therapy by means of pulmonary balloon-angioplasty (BPA) or medical therapy is indicated. In Germany, the majority of the patients is referred to three CTEPH centers: Kerckhoff Clinic, Saarland University Hospital and Hannover Medical School to evaluate the therapeutic options. Starting in January 2016 all incident patients will be de-identified and included prospectively. Risk factors, outcome and treatment will be documented.

Conditions

  • Chronic Thromboembolic Pulmonary Hypertension
  • CTEPH

Interventions

OTHER

Registration of the diagnosis "CTEPH"

Registration of risk factors for thromboembolic events

Sponsors & Collaborators

  • Hannover Medical School

    collaborator OTHER

  • University Hospital, Saarland

    collaborator OTHER

  • Kerckhoff Klinik

    lead OTHER

Principal Investigators

  • Eckhard Mayer, Prof. Dr. · Kerckhoff Klinik, Bad Nauheim, Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02660463 on ClinicalTrials.gov